Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Benfenati

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Haematologica|November 1, 1989
Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL)P Tosi, G Visani, R Colombini, et al.
Leukemia & Lymphoma|January 1, 1994
Retreatment with 2-CdA of progressed HCL patientsF Lauria, D Benfenati, D Raspadori, et al.
Leukemia & Lymphoma|January 1, 1994
Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapiesS Pileri, E Sabattini, S Poggi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphomaP L Zinzani, F Lauria, D Rondelli, et al.
European Journal of Haematology|August 1, 1993
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemiaP L Zinzani, F Lauria, D Rondelli, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Haematologica|November 1, 1989
Phase II study of bisantrene in relapsed/refractory acute non lymphoid leukemias (ANLL)P Tosi, G Visani, R Colombini, et al.
Leukemia & Lymphoma|January 1, 1994
Retreatment with 2-CdA of progressed HCL patientsF Lauria, D Benfenati, D Raspadori, et al.
Leukemia & Lymphoma|January 1, 1994
Bone-marrow biopsy in hairy cell leukaemia (HCL) patients. Histological and immunohistological analysis of 46 cases treated with different therapiesS Pileri, E Sabattini, S Poggi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 1, 1993
Fludarabine: an active agent in the treatment of previously-treated and untreated low-grade non-Hodgkin's lymphomaP L Zinzani, F Lauria, D Rondelli, et al.
European Journal of Haematology|August 1, 1993
Fludarabine in patients with advanced and/or resistant B-chronic lymphocytic leukemiaP L Zinzani, F Lauria, D Rondelli, et al.
Pageof 2